Serum 25-hydroxyvitamin D and cognitive decline in the very old: The Newcastle 85+ study

European Journal of Neurology

Volumn 22, Issue 1, 2015, Pages 106-115

  Granic, A ^a   Hill, T R ^a,b   Kirkwood, T B L ^a   Davies, K ^a   Collerton, J ^a   Martin Ruiz, C ^a   von Zglinicki, T ^a   Saxby, B K ^a   Wesnes, K A ^c,d   Collerton, D ^a   Mathers, J C ^a   Jagger, C ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c Wesnes Cognition Ltd   (United Kingdom)

^d NORTHUMBRIA UNIVERSITY   (United Kingdom)

Author keywords

25 hydroxyvitamin D; Attention; Cognitive decline; Cohort study

Indexed keywords

25 HYDROXYVITAMIN D; FOLIC ACID; 25-HYDROXYVITAMIN D; VITAMIN D;

AGED; ALERTNESS; ARTICLE; BLOOD SAMPLING; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DRUG RESEARCH; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPONSE TIME; VERY ELDERLY; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ATTENTION; BLOOD; COGNITION DISORDERS; GREAT BRITAIN; PHYSIOLOGY; PREVALENCE; SEASON; VITAMIN D DEFICIENCY;

AGED, 80 AND OVER; ATTENTION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; PREVALENCE; SEASONS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84923104929     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12539     Document Type: Article

References (50)

1. Balion C, Griffith LE, Strifler L, et al. Vitamin D, cognition, and dementia. Neurology 2012; 79: 1397-1405.
2. Kesby JP, Eyles DW, Burne THJ, Burne THJ, McGrath JJ. The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol 2011; 347: 121-127.
3. Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012; 5: 819-829.
4. IARC. Vitamin D and Cancer. IARC Working Group Reports Vol. 5. Lyon, France: International Agency for Research on Cancer, 2008.
5. Chowdhury R, Kunutsor S, Vitezova A, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomized intervention studies. BMJ 2014; 348: g1903.
6. Durup D, Jørgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD Study. J Clin Endocrinol Metab 2012; 97: 2644-2652.
7. Institute of Medicine (IOM). Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press, 2011.
8. Dror Y, Giveon SM, Hoshen M, Feldhamer I, Balicer RD, Feldman BS. Vitamin D levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J Clin Endocrinol Metab 2013; 98: 2160-2167.
9. Hirani V, Primatesta P. Vitamin D concentrations among people aged 65 years and over living in private households and institutions in England: population study. Age Ageing 2005; 34: 485-491.
10. Ovesen L, Andersen R, Jakobsen J. Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc 2003; 62: 813-821.
11. Holick MF. Vitamin D: a D-lightful health perspective. Nutr Rev 2008; 66: S182-S194.
12. Sanders KM, Nicholson GC, Ebeling PR. Is high dose vitamin D harmful? Calcif Tissue Int 2013; 92: 191-206.
13. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014; 1: CD007470.
14. Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 2007; 158: 1-235.
15. Annweiler C, Schott AM, Allali G, et al. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010; 74: 27-32.
16. Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci 2011; 66: 59-65.
17. Buell JS, Scott TM, Dawson-Hughes B, et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009; 64: 888-895.
18. Hansen AL, Dahl L, Bakke L, Thayer JF. Vitamin D and executive function: a preliminary report. Percept Mot Skills 2011; 113: 667-685.
19. Lee DM, Tajar A, Ulubaev A, et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged older European men. J Neurol Neurosurg Psychiatry 2009; 80: 722-729.
20. Saemans KM, Hill TR, Scully L, et al. Vitamin D status and measures of cognitive function in healthy older European adults. Eur J Clin Nutr 2010; 64: 1172-1178.
21. McGrath J, Scragg R, Chant D, Eyles D, Burne T, Obradovic D. No association between serum 25-hydroxyvitamin D3 levels and performance on psychometric tests in NHANES III. Neuroepidemiology 2007; 29: 49-54.
22. Slinin Y, Paudel ML, Taylor BC, et al. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 2010; 74: 33-41.
23. Slinin Y, Paudel M, Taylor BC, et al. Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. J Gerontol A Biol Sci Med Sci 2012; 67: 1092-1098.
24. Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010; 170: 1135-1141.
25. Wilson VK, Houston DK, Kilpatrick L, et al. Relationship between 25-hydroxyvitamin D and cognitive function in older adults: the health, aging and body composition study. J Am Geriatr Soc 2014; 62: 636-641.
26. Formiga F, Ferrer A, Almeda J, San Jose A, Gil A, Pujol R. Utility of geriatric assessment tools to identify 85-years old subjects with vitamin D deficiency. J Nutr Health Aging 2011; 15: 110-114.
27. Menant JC, Close JC, Delbaere K, et al. Relationship between serum vitamin D levels, neuromuscular and neuropsychological function and falls in older men and women. Osteoporos Int 2012; 23: 981-989.
28. Collerton J, Barrass K, Bond J, et al. The Newcastle 85+ study: biological, clinical and psychological factors associated with healthy ageing: study protocol. BMC Geriatr 2007; 7: 14.
29. Collerton J, Davies K, Jagger C, et al. Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ 2009; 399: b4904.
30. Martin-Ruiz C, Jagger C, Kingston A, et al. Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ Study. Mech Ageing Dev 2011; 132: 496-502.
31. Vertesi A, Lever JA, Molloy DW, et al. Standardized Mini-Mental State Examination. Can Fam Physician 2001; 47: 2018-2023.
32. Molloy DW, Standish TI. A guide to standardize Mini-Mental State Examination. Int Psychogeriatr 1997; 9: 87-94.
33. Hensel A, Angermeyer MC, Riedel-Heller SG. Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination. J Neurol Neurosurg Psychiatry 2007; 78: 1298-1303.
34. Tombaugh TN. Test-retest reliable coefficients and 5-year change scores for the MMSE and 3ME. Arch Clin Neuropsychol 2005; 20: 485-503.
35. Simpson PM, Surmon DJ, Wesnes KA, Wilcock GK. The cognitive drug research computerized assessment system for demented patients: a validation study. Int J Geriatr Psychiatry 1991; 6: 95-102.
36. Wesnes KA. Assessing change in cognitive function in dementia: the relative utilities of the Alzheimer's Disease Assessment Scale - Cognitive Subscale and the Cognitive Drug Research System. Neurodegener Dis 2008; 5: 261-263.
37. Wesnes KA, Ward T, McGinty A, Petrini O. The memory enhancing effects of a Ginko biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology 2000; 152: 353-361.
38. Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention. PD dementia vs DLB with parkinsonism. Neurology 2002; 59: 1714-1720.
39. Wesnes KA, McKeith I, Edgar C, Emre M, Lane R. Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology 2005; 65: 1654-1656.
40. Collerton J, Collerton D, Arai Y, et al. A comparison of computerized and pencil-and-paper task in assessing cognitive function in community-dwelling older people in the Newcastle 85+ pilot study. J Am Geriatr Soc 2007; 55: 1630-1635.
41. Shoben AB, Kestenbaum B, Levin G, et al. Seasonal variation in 25-hydroxyvitamin D concentrations in the Cardiovascular Health Study. Am J Epidemiol 2011; 174: 1363-1372.
42. Wang Y, Jacobs EJ, McCullough ML, et al. Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulation based on serum 25-hydroxyvitamin D. Am J Epidemiol 2009; 170: 88-94.
43. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence, 1st edn. New York, NY: Oxford University Press, 2003.
44. Ibi M, Sawada H, Nakanishi M, et al. Protective effect of 1 alpha, 25-(OH)(2)D-3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 2001; 40: 761-771.
45. Granic A, Aspray T, Hill T, et al. 25-hydroxyvitamin D and increased all-cause mortality in the very old women: the Newcastle 85+ study. J Intern Med 2014; doi: 10.1111/joim.12273 [Epub ahead of print].
46. Johansson P, Almqvist EG, Johansson J-O, et al. Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease. PLoS One 2013; 8: e81989.
47. Rowan E, McKeith IG, Saxby BK, et al. Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies. Dement Geriatr Cogn Disord 2007; 23: 161-167.
48. Wesnes K, Edgar C, Andreasen N, et al. Computerized cognition assessment during acelylcholinesterase inhibitor treatment in Alzheimer's disease. Acta Neurol Scand 2010; 122: 270-277.
49. Bronnick K, Ehrt U, Emre M, et al. Attention deficits affect activities of daily living in dementia associated with Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 1136-1142.
50. Dhesi JK, Jackson SH, Bearne LM, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 2004; 33: 589-595.